Top compounds associated with response to C6orf226

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Nilotinib	CCLE	pan-cancer	AAC	-0.13	0.01
mRNA	tretinoin:carboplatin (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.089	0.01
mRNA	CI-1040	GDSC1000	pan-cancer	AAC	-0.081	0.01
mRNA	ATRA	GDSC1000	pan-cancer	AAC	-0.083	0.01
mRNA	Rapamycin	GDSC1000	pan-cancer	AAC	0.12	0.01
mRNA	Gemcitabine	GDSC1000	pan-cancer	AAC	-0.086	0.01
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.083	0.01
mRNA	selumetinib:decitabine (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.083	0.01
mRNA	epigallocatechin-3-monogallate	CTRPv2	pan-cancer	AAC	0.087	0.02
mRNA	BMS-536924	GDSC1000	pan-cancer	AAC	-0.077	0.02

Download CSV